Log in to save to my catalogue

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agen...

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_204197060

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors

About this item

Full title

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Cancer biotherapy & radiopharmaceuticals, 2008-04, Vol.23 (2), p.158

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

The epidermal growth-factor receptor (EGFR) and its ligands have been recognized as critical factors in the pathophysiology of tumorigenesis. Overexpression of the EGFR plays a significant role in the tumor progression of a wide variety of solid human cancers. Therefore, the EGFR represents an attractive target for the design of novel diagnostic an...

Alternative Titles

Full title

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_204197060

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_204197060

Other Identifiers

ISSN

1084-9785

E-ISSN

1557-8852

DOI

10.1089/cbr.2007.0444

How to access this item